Cancer, in addition to many other chronic diseases, is associated with serious and problematic behavioral symptoms, including cognitive impairments. In humans, various factors likely contribute to cancer-associated cognitive deficits including disease awareness and chemotherapy; however, the endogenous biological factors arising from tumor development may also play a causal role. In the present study, rats with mammary tumors exhibited impaired spatial reference memory on a radial arm maze and amnesia for familiar objects in an object recognition memory test. In contrast, their performance in the Morris water maze and in fear conditioning tests was comparable to that of controls. These select cognitive impairments were accompanied by elevations in hippocampal interleukin-1b mRNA expression, but were not associated with decreases in hippocampal brain-derived neurotrophic factor gene expression. Together the results indicate that peripheral tumors alone are sufficient to induce increases in hippocampal cytokine expression and select deficits in hippocampal-dependent memory tasks.
Introduction
Cancer patients commonly experience emotional distress and cognitive impairments (Wefel et al., 2008) , which reduce their quality of life and negatively impact treatment compliance and survival (Brown et al., 2003) . Cognitive impairments associated with cancer include deficits in memory, attention, concentration, and problem solving skills (Wefel et al., 2008) . Prior research has emphasized deleterious effects of chemotherapy on cognition (Miller et al., 2008) ; however, mechanisms by which tumors alone affect cognition remain largely unexamined.
Peripheral tumors are sufficient to induce a negative emotional state and trigger parallel changes in the immune and endocrine systems. Rats with mammary tumors exhibit elevated hippocampal proinflammatory cytokines (including interleukin-1b ), decreased glucocorticoid production, and increased hippocampal glucocorticoid receptor gene expression (Pyter et al., 2009) . In light of the potent negative effects of proinflammatory cytokines (Banks et al., 2002) , and modulatory effects of glucocorticoids (Wolf, 2003) , on cognition, the present work considered whether tumors alone are likewise sufficient to disrupt learning and memory.
To examine this, we assessed several modalities of learning and memory in tumor-bearing and tumor-free rats. We also examined hippocampal proinflammatory cytokine production and growth factor gene expression as possible mediators of tumor-induced changes in hippocampal-dependent memory processes.
Methods

Animals
Female, nulliparous Wistar rats (Harlan, Indianapolis, IN) were used in these experiments. Siblings were pseudo-randomly distributed among treatments and housed 2-3/cage in polypropylene cages (25.9 Â 47.6 Â 20.9 cm) at temperature and humidity of 22 ± 1°C and 50 ± 5%, respectively, and ad libitum access to food (Harlan 2018) and filtered tap water. Rats were housed in 16 h light/day (lights on: 20.00 h CST) and all behavioral tests were performed between 7.00 and 13.00 h CST. Two treatment-balanced cohorts of rats were tested using the Morris water maze and fear conditioning paradigms (n = 14 tumors; n = 12 saline). Separate cohorts were used for radial arm maze (n = 4 tumors; n = 5 saline), novel object recognition test/BDNF gene expression (n = 20 tumors; n = 13 saline), and hippocampal IL-1b gene expression (n = 3 tumors; n = 3 saline).
Tumor induction
Between 30-42 d of age (week 0), rats received an injection (i.p., 50 mg/kg) of the carcinogen (N-nitroso-N-methylurea [NMU]; Sig-
